PT586

N/A

Report date: 2024/05/22 15:08:54

Base Information

Drug NamePT586

Drug Alias NamePT586

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionAnti-Cluster of differentiation 47

TargetsCluster of differentiation 47

Therapy Area/IndicationsGlioblastoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesPhanes Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesPhanes Therapeutics Inc

Inactive CompaniesN/A

Active IndicationsGlioblastoma

Inactive IndicationsN/A

Other Information

ATC CodeN/A